Latest Insider Transactions at Age X Therapeutics, Inc. (AGE)
This section provides a real-time view of insider transactions for Age X Therapeutics, Inc. (AGE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AgeX Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AgeX Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2021
|
Michael D West Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,284
-3.81%
|
$2,568
$2.03 P/Share
|
|
Mar 11
2021
|
Michael D West Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+8.48%
|
-
|
|
Dec 11
2020
|
Michael D West Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,081
-3.41%
|
$1,081
$1.69 P/Share
|
|
Dec 11
2020
|
Michael D West Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+8.98%
|
-
|